In situ and localized primary invasive pregnancy‐associated melanoma: Maternal and perinatal outcomes
Diagnosis of early PAM in pregnancy or postpartum is not associated with significant adverse outcomes for women or their babies. Early diagnosis remains important to ensure appropriate treatment and positive outcomes.
Authors
- Nadom Safi (ORCID: https://orcid.org/0000-0001-8473-0980)
- Penelope Fotheringham (ORCID: https://orcid.org/0000-0003-1853-8194)
- Marc Rémond (ORCID: https://orcid.org/0000-0001-7796-4447)
- Serigne Lo (ORCID: https://orcid.org/0000-0001-5092-5544)
- Linda K. Martin (ORCID: https://orcid.org/0000-0001-9519-7077)
- Antoinette Catherine Anazodo (ORCID: https://orcid.org/0000-0002-5495-6062)
- Elizabeth Sullivan (ORCID: https://orcid.org/0000-0002-8718-2753)
Institutions
- University of Technology Sydney (AU)
- The University of Sydney (AU)
- UNSW Sydney (AU)
- Hunter Medical Research Institute (AU)
- Melanoma Institute Australia (AU)
- Sydney Children's Hospital (AU)
- University of Newcastle Australia (AU)
- Neuroscience Research Australia (AU)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1111/jdv.20894
- Citations
- 2
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Cancer Council NSW